Scientech Research LLC Corcept Therapeutics Inc Transaction History
Scientech Research LLC
- $378 Billion
- Q1 2025
A detailed history of Scientech Research LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Scientech Research LLC holds 14,181 shares of CORT stock, worth $991,393. This represents 0.43% of its overall portfolio holdings.
Number of Shares
14,181
Previous 18,897
24.96%
Holding current value
$991,393
Previous $952 Million
70.1%
% of portfolio
0.43%
Previous 0.27%
Shares
2 transactions
Others Institutions Holding CORT
# of Institutions
472Shares Held
84.3MCall Options Held
1.43MPut Options Held
2.75M-
Black Rock Inc. New York, NY16.5MShares$1.16 Billion0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.98MShares$698 Million0.02% of portfolio
-
Ingalls & Snyder LLC New York, NY7.74MShares$541 Million29.09% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.14MShares$429 Million1.13% of portfolio
-
Parallel Advisors, LLC3.87MShares$271 Million5.83% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $7.49B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...